BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Cancer
BioWorld Science, Cancer
RSS
Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials
Oct. 18, 1996
Broader role of VEGF in tumor growth proposed
Oct. 18, 1996
Chemokine/cytokine combination effective for tumor therapy
Oct. 18, 1996
Japanese researchers report new antitumor antibiotics
Oct. 18, 1996
Kyowa Hakko reports antiestrogenic agents
Oct. 18, 1996
Gene therapy reduces the side effects of chemotherapy
Oct. 11, 1996
New strategy for reducing doxorubicin toxicity
Oct. 11, 1996
First photodynamic therapy approved in the U.S.
Oct. 11, 1996
Clinical trial program for anticancer HER-2/neu inhibitor
Oct. 11, 1996
SuperGen acquires rights to Warner-Lambert anticancer drug
Oct. 11, 1996
Previous
1
2
…
3632
3633
3634
3635
3636
3637
3638
3639
3640
…
3671
3672
Next
RSS